# Medistaff Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/medistaff-co

- Industry: Healthcare IT
- Headquarters: Seoul, South Korea
- Website: www.medistaff.co.kr/
- Total disclosed funding: $6.5M
- Latest round: Series B (Aug 12, 2025)
- Investors on record: 6

## About

Based in Gyeonggi-do, South Korea, and founded in 2016, Medistaff Co., Ltd., is a software company that offers a secure messaging platform for doctors. In August 2025, Medistaff Co., Ltd. raised KRW 5 billion in series B funding from new investors Dunamu & Partners and Wooshin Venture Capital. The company offers a messenger platform called ‘Kakao Talk of 2040-generation doctors', with end-to-end encrypted security features to prevent access by third parties. The messages sent or received through Medistaff's solution are automatically deleted after 3 days to allow doctors to chat safely. The company’s platform also features customized bulletin boards and club services, such as academic exchanges, real-time medical news, hospital evaluations of national majors, internship application status, doctor invitations, and a place to gather the latest medical trends and insights. The company will use the 2025 funding to further improve its platform, develop new services and broaden the scope of its business.

## Funding rounds

- Series B, Aug 12, 2025, $3.6M — Wooshin Venture Capital, Dunamu & Partners
- Series A, Mar 4, 2024, $1.9M — CKD Venture Capital, Hana Ventures
- Series A, Sep 28, 2022, $1M — Prodigy Investment, J Curve Investment

## Investors

- Prodigy Investment (https://capitalatlas.ai/funds/prodigy-investment) — Series A
- J Curve Investment (https://capitalatlas.ai/funds/j-curve-investment) — Series A
- CKD Venture Capital (https://capitalatlas.ai/funds/ckd-venture-capital) — Series A
- Hana Ventures — Series A
- Wooshin Venture Capital (https://capitalatlas.ai/funds/wooshin-venture-capital) — Series B
- Dunamu & Partners (https://capitalatlas.ai/funds/dunamu-partners) — Series B